Simsen Diagnostics
PrivateLast Round
Early Funding
May 5, 2026
Total Funding Raised
$1.41M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Simsen Diagnostics is a healthcare technology company that specializes in ultra-sensitive, personalized blood tests that detect and monitor cancer by analyzing circulating tumor DNA (ctDNA).
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Simsen Diagnostics Comparables
Compare Simsen Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Natera, Inc. | 79% | |
| NeoGenomics Inc | 78% | |
| Personalis Inc | 78% |
Simsen Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 5, 2026 | ||||
| Grant | Apr 23, 2024 | ||||
| Grant | Nov 9, 2022 |
Key People
Founding team and executive leadership
Simsen Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Swedish Research Council for Sustainable Development (Formas) | Grant |
| Vasa Angels I | Early Funding |
| Vinnova | Grant |
| J.F.B Invest | Early Funding |
| Swelife | Grant |
| Nordic Ignite | Early Funding |
| Gobia Enterprises | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors grew 54% MoM.
- May 5, 2026
$1.08M raised, led by Gobia Enterprises.
Simsen Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Simsen Diagnostics's valuation, stock price, and market status.
Is Simsen Diagnostics a public or private company?
Simsen Diagnostics is a private company.
What is the current stock price of Simsen Diagnostics?
Simsen Diagnostics is a private company with no public stock price. No recent secondary market data is available.
How much is Simsen Diagnostics worth (valuation)?
Valuation information for Simsen Diagnostics is not publicly available.
Can I buy Simsen Diagnostics stock?
Simsen Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Simsen Diagnostics's last funding round?
Simsen Diagnostics's most recent funding round was Early Funding on May 5, 2026.
Who are the main investors in Simsen Diagnostics?
Key investors in Simsen Diagnostics include Gobia Enterprises.
Will Simsen Diagnostics IPO soon?
No public IPO plans have been announced for Simsen Diagnostics.
How can I track Simsen Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Simsen Diagnostics's secondary market activity and sign up for updates.